Association of serum bilirubin and non-alcoholic fatty liver disease: A feasible therapeutic avenue?

doi:10.5497/wjp.v3.i4.209

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11181)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

390

WORD

304

HTML

7848

Figures (1-1)

154

Tables (1-2)

144

Sum=8840

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1112

Download

1229

Sum=2341

Dec 9, 2014 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Pharmacology

ISSN

2220-3192

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Pharmacol. Dec 9, 2014; 3(4): 209-216
Published online Dec 9, 2014. doi: 10.5497/wjp.v3.i4.209

Open in New Tab Full Size Figure Download Figure

Figure 1 Flow chart describing the selection process for publication to be included in this review.

Citation: Anwar MS, Dillon JF, Miller MH. Association of serum bilirubin and non-alcoholic fatty liver disease: A feasible therapeutic avenue? World J Pharmacol 2014; 3(4): 209-216
URL: https://www.wjgnet.com/2220-3192/full/v3/i4/209.htm
DOI: https://dx.doi.org/10.5497/wjp.v3.i4.209